{"transactions":[{"id":717502,"issuer":{"id":6975,"kind":"organization","name":"NOMAD POWER SOLUTIONS, INC."},"owners":[{"id":32713,"kind":"person","name":"Stazzone Peter","position":1,"cik":"0002083297","reported_name":"Stazzone Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T20:18:44.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction involved the Reporting Person's receipt of 50,000 restricted share units (\"RSUs\"). The RSUs were granted pursuant to the applicable RSU agreement and the Lixte Biotechnology Holdings, Inc. 2020 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting, subject to continued service. The 50,000 RSUs vested upon the achievement of the performance conditions set forth in the Reporting Person's RSU agreement, which have been satisfied."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total reported in Column 5 includes (i) the 50,000 newly awarded RSUs, and (ii) 50,000 RSUs, all of which have vested."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001493152-26-031896","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226031896/ownership.xml","form_type":"4"}},{"id":805273,"issuer":{"id":6975,"kind":"organization","name":"NOMAD POWER SOLUTIONS, INC."},"owners":[{"id":32713,"kind":"person","name":"Stazzone Peter","position":1,"cik":"0002083297","reported_name":"Stazzone Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to Purchase Common Stock","published_at":"2026-04-17T20:15:38.000Z","date":"2026-04-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 15, 2026, the Issuer canceled, pursuant to that certain Stock Option Cancellation Agreement dated April 15, 2026 between the Issuer and the Reporting Person, the 50,000 options (the \"Options\") granted to the Reporting Person on September 1, 2025. In exchange for the Options, the Reporting Person received 50,000 restricted share units (\"RSUs\"). The RSUs were granted pursuant to the applicable award agreement dated April 15, 2026 and the Lixte Biotechnology Holdings, Inc. 2020 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting, subject to continued service. The 50,000 RSUs vest immediately upon grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The canceled Options provided for vesting 25% on September 1,2025, 25% on December 15,2025, 25% on March 15,2026, and 25% on June 15,2026."}],"balance_after":0,"derivative":{"exercise_price":4.45,"expiration_date":"2030-09-01","underlying":"Common","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-26-017857","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226017857/ownership.xml","form_type":"4"}},{"id":805272,"issuer":{"id":6975,"kind":"organization","name":"NOMAD POWER SOLUTIONS, INC."},"owners":[{"id":32713,"kind":"person","name":"Stazzone Peter","position":1,"cik":"0002083297","reported_name":"Stazzone Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-17T20:15:38.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 15, 2026, the Issuer canceled, pursuant to that certain Stock Option Cancellation Agreement dated April 15, 2026 between the Issuer and the Reporting Person, the 50,000 options (the \"Options\") granted to the Reporting Person on September 1, 2025. In exchange for the Options, the Reporting Person received 50,000 restricted share units (\"RSUs\"). The RSUs were granted pursuant to the applicable award agreement dated April 15, 2026 and the Lixte Biotechnology Holdings, Inc. 2020 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting, subject to continued service. The 50,000 RSUs vest immediately upon grant."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001493152-26-017857","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226017857/ownership.xml","form_type":"4"}},{"id":1047660,"issuer":{"id":6975,"kind":"organization","name":"NOMAD POWER SOLUTIONS, INC."},"owners":[{"id":32713,"kind":"person","name":"Stazzone Peter","position":1,"cik":"0002083297","reported_name":"Stazzone Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options to Purchase Common Stock","published_at":"2025-09-04T18:58:31.000Z","date":"2025-09-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Effective September 1, 2025, the reporting person was granted stock options to purchase 50,000 shares vesting vesting 25% on September 1,2025, 25% on December 15,2025, 25% on March 15,2026, and 25% on June 15,2026., subject to continuous service and acceleration upon the occurrence of certain events. The grant was in connection with the reporting person being appointed as the Company's Chief Financial Officer. The exercise price is $4.45 per share."}],"balance_after":50000,"derivative":{"exercise_price":4.45,"exercise_date":"2025-09-01","expiration_date":"2030-09-01","underlying":"Common","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001641172-25-026560","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1335105/000164117225026560/ownership.xml","form_type":"4"}}]}